Skip to main content

Palliative Telecare Team Aids QOL, Health Status for Chronic Conditions

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 23, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, Jan. 23, 2024 -- Use of a nurse and social worker palliative telecare team is associated with clinically meaningful improvements in quality of life at six months for adults with chronic obstructive pulmonary disease (COPD), heart failure, or interstitial lung disease (ILD) versus usual care, according to a study published in the Jan. 16 issue of the Journal of the American Medical Association.

David B. Bekelman, M.D., M.P.H., from the Eastern Colorado Health Care System in Aurora, and colleagues evaluated the effect of a nurse and social worker palliative telecare team on quality of life in outpatients with COPD, heart failure, and ILD versus usual care. The analysis included 306 participants randomly assigned to the intervention (six phone calls with a nurse for symptom management and six phone calls with a social worker for psychosocial care) or usual care.

The researchers reported that the mean length of intervention was 115.1 days and included a mean 10.4 intervention calls per patient. At six-month follow-up, the mean Functional Assessment of Chronic Illness Therapy–General (FACT-G) score improved 6.0 points in the intervention group versus 1.4 points in the usual care group (standardized mean difference, 0.41). The intervention was also associated with improved health status for COPD (standardized mean difference, 0.44), heart failure (0.41), depression (−0.50), and anxiety (−0.51).

"The virtual and population approach of this intervention lends itself to a hub and spoke model that can improve the reach of palliative care services to areas that may be traditionally underresourced," the authors write.

Several authors disclosed ties to relevant medical organizations.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted January 2024

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Vaginal Cancer Incidence Increasing Globally

WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.